Reports from AstraZeneca Highlight Recent Findings in COVID-19 [Azd7442 (Tixagevimab/cilgavimab) for Post-exposure Prophylaxis of Symptomatic Coronavirus Disease 2019]

Press/Media

Period19 Jan 2023

Media coverage

1

Media coverage

  • TitleReports from AstraZeneca Highlight Recent Findings in COVID-19 [Azd7442 (Tixagevimab/cilgavimab) for Post-exposure Prophylaxis of Symptomatic Coronavirus Disease 2019]
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date19/01/23
    PersonsSimon Pollett